Chief Financial Officer, Co-Founder
David Ramsay is a co-founder and has served as our Chief Financial Officer since February 2018. From June 2015 to February 2018, Mr. Ramsay served as an independent director on our board of directors. Mr. Ramsay retired from Halozyme Therapeutics, Inc., a public biotechnology company, in July 2015 as Chief Financial Officer, responsible for leading the finance, accounting, reporting, tax, treasury, investor relations, information technology and commercial organizations. He joined Halozyme in 2003 and was part of the management team that helped guide the company through the successful development and commercialization of its first products. Mr. Ramsay received his B.S. in Business Administration from the University of California, Berkeley, and his M.B.A. in Finance and Strategic Management from The Wharton School at the University of Pennsylvania.